Study of P53 Gene Alteration as a Biomarker to Evaluate the Malignant Risk of Lugol-Unstained Lesion With Non-Dysplasia in the Oesophagus
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603582
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2007
Authors
Publisher
Springer Science and Business Media LLC